$NRXP $RLFTF NRx Pharmaceuticals Announces Positive Results for ZYESAMI™ (Aviptadil-acetate) and Submits Emergency Use Authorization Application to US FDA to Treat Critical COVID-19 in Patients Suffering from Respiratory Failure
JUNE 01, 2021 6:28AM
https://ir.nrxpharma.com/news-events/press-re...esults-for